PhD Science Writer, New York, New York, USA.
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Ann N Y Acad Sci. 2022 Dec;1518(1):209-225. doi: 10.1111/nyas.14898. Epub 2022 Oct 2.
The COVID-19 pandemic caught the world largely unprepared, including scientific and policy communities. On April 10-13, 2022, researchers across academia, industry, government, and nonprofit organizations met at the Keystone symposium "Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases" to discuss the successes and challenges of the COVID-19 pandemic and what lessons can be applied moving forward. Speakers focused on experiences not only from the COVID-19 pandemic but also from outbreaks of other pathogens, including the Ebola virus, Lassa virus, and Nipah virus. A general consensus was that investments made during the COVID-19 pandemic in infrastructure, collaborations, laboratory and manufacturing capacity, diagnostics, clinical trial networks, and regulatory enhancements-notably, in low-to-middle income countries-must be maintained and strengthened to enable quick, concerted responses to future threats, especially to zoonotic pathogens.
COVID-19 大流行让包括科学界和政策界在内的世界措手不及。2022 年 4 月 10 日至 13 日，来自学术界、工业界、政府和非营利组织的研究人员在 Keystone 研讨会“大流行的教训：应对新兴人畜共患病毒疾病”上会面，讨论 COVID-19 大流行的成功和挑战，以及可以为未来应用哪些经验。演讲者不仅关注 COVID-19 大流行的经验，还关注其他病原体的暴发，包括埃博拉病毒、拉沙病毒和尼帕病毒。一个普遍共识是，必须维持和加强在 COVID-19 大流行期间在基础设施、合作、实验室和制造能力、诊断、临床试验网络和监管加强方面的投资——特别是在中低收入国家——以实现对未来威胁的快速、协调应对，尤其是对人畜共患病原体的威胁。
